# Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia

> **NCT02534818** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 180 (estimated)

## Conditions studied

- Gastric Intestinal Metaplasia

## Interventions

- **DRUG:** lower fluorescein sodium dosage 0.02ml/kg
- **DRUG:** conventional fluorescein sodium dosage 0.1ml/kg

## Key facts

- **NCT ID:** NCT02534818
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2015-11
- **Final completion:** —
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2015-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02534818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02534818, "Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02534818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*